Physician

Anil K Gehi, M.D.

According to 2025 Medicare claims, Anil Gehi, M.D. (NPI: 1316120017) practices cardiac electrophysiology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Orange, NC. This provider's primary affiliated billing organization is UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (NPI: 1780669200; TIN: 561732213) and primary practice location at 27514-4220. Gehi is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Gehi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 665 traditional Medicare patients, billed 2,042 HCPCS/CPT codes, and received $132,894 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 962 prescription claims across 208 beneficiaries totaling $335,862 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 90 records totaling $7,284. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $146,098 to $335,862. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $33,982 to $1,778.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,124	2,612	$178,005
2016	1,064	2,450	$193,321
2017	1,093	2,556	$184,127
2018	937	1,868	$139,619
2019	918	2,045	$154,535
2020	979	1,861	$149,054
2021	1,033	2,028	$157,932
2022	886	1,586	$149,981
2023	733	1,747	$125,364
2024	665	2,042	$132,894

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	805	$146,098
2016	166	955	$229,982
2017	187	992	$276,967
2018	219	1,192	$411,228
2019	235	1,103	$397,215
2020	198	843	$360,135
2021	197	862	$355,680
2022	202	912	$388,545
2023	198	870	$351,371
2024	208	962	$335,862

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$33,304
2016	N/R	N/R	N/R
2017	N/R	12	$302
2018	N/R	11	$319
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$1,328
2022	N/R	N/R	N/R
2023	N/R	36	$2,486
2024	N/R	12	$891

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	56	57	$665
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	150	$67
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	82	260	$25
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	143	451	$19
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	287	373	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	168	9,406	$180,755
Xarelto	Rivaroxaban	49	3,630	$66,547
Multaq	Dronedarone Hcl	32	2,118	$55,550
Dofetilide	Dofetilide	48	2,867	$3,789
Flecainide Acetate	Flecainide Acetate	73	5,200	$3,142

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$891

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	90	$7,284	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anil K. Gehi, M.D.?

Tedicare shows public-source Medicare data for Anil K. Gehi, M.D. (NPI 1316120017), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil K. Gehi, M.D. have ACO affiliation data?

Anil K. Gehi, M.D. is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Anil K. Gehi, M.D.?

Anil K. Gehi, M.D. is linked to UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (billing NPI 1780669200) in the available physician profile data.

Does Anil K. Gehi, M.D. have Open Payments data?

Anil K. Gehi, M.D. has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.